Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Thomas P. Fabrizio"'
Autor:
Hyunsuh Kim, Patrick Seiler, Jeremy C. Jones, Granger Ridout, Kristi P. Camp, Thomas P. Fabrizio, Trushar Jeevan, Lance A. Miller, Robert E. Throm, Francesca Ferrara, Richard L. Fredrickson, James F. Lowe, Leyi Wang, Solomon O. Odemuyiwa, Xiu-Feng Wan, Richard J. Webby
Publikováno v:
Vaccines, Vol 8, Iss 4, p 684 (2020)
To optimize the public health response to coronavirus disease 2019 (COVID-19), we must first understand the antibody response to individual proteins on the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) and the antibody’s cros
Externí odkaz:
https://doaj.org/article/a739dbd368f34f4896832f46bf922aa8
Autor:
Mark G, Thompson, Sarang K, Yoon, Allison L, Naleway, Jennifer, Meece, Thomas P, Fabrizio, Alberto J, Caban-Martinez, Jefferey L, Burgess, Manjusha, Gaglani, Lauren E W, Olsho, Allen, Bateman, Jessica, Lundgren, Lauren, Grant, Andrew L, Phillips, Holly C, Groom, Elisha, Stefanski, Natasha Schaefer, Solle, Katherine, Ellingson, Karen, Lutrick, Kayan, Dunnigan, Meredith G, Wesley, Kyley, Guenther, Angela, Hunt, Josephine, Mak, Kurt T, Hegmann, Jennifer L, Kuntz, Adam, Bissonnette, James, Hollister, Spencer, Rose, Tyler C, Morrill, Karley, Respet, Ashley L, Fowlkes, Matthew S, Thiese, Patrick, Rivers, Meghan K, Herring, Marilyn J, Odean, Young M, Yoo, Matthew, Brunner, Edward J, Bedrick, Deanna E, Fleary, John T, Jones, Jenna, Praggastis, James, Romine, Monica, Dickerson, Sana M, Khan, Julie Mayo, Lamberte, Shawn, Beitel, Richard J, Webby, Talesha, Jones
Publikováno v:
JAMA
ImportanceData on the epidemiology of mild to moderately severe COVID-19 are needed to inform public health guidance.ObjectiveTo evaluate associations between 2 or 3 doses of mRNA COVID-19 vaccine and attenuation of symptoms and viral RNA load across
Autor:
Diego R, Hijano, Zhengming, Gu, Jessica, Brazelton, Haiqing, Zhu, Sri, Suganda, Heather L, Glasgow, Himani, Darji, Li, Tang, Thomas P, Fabrizio, Kim J, Allison, E Kaitlynn, Allen, Aditya H, Gaur, Joshua, Wolf, Paul G, Thomas, Richard J, Webby, Elaine I, Tuomanen
Publikováno v:
Open Forum Infectious Diseases. 9
Although numerous studies have evaluated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection using cycle threshold (Ct) values as a surrogate of viral ribonucleic acid (RNA) load, few studies have used standardized, quantitative me
Autor:
Marciela M. DeGrace, Elodie Ghedin, Matthew B. Frieman, Florian Krammer, Alba Grifoni, Arghavan Alisoltani, Galit Alter, Rama R. Amara, Ralph S. Baric, Dan H. Barouch, Jesse D. Bloom, Louis-Marie Bloyet, Gaston Bonenfant, Adrianus C. M. Boon, Eli A. Boritz, Debbie L. Bratt, Traci L. Bricker, Liliana Brown, William J. Buchser, Juan Manuel Carreño, Liel Cohen-Lavi, Tamarand L. Darling, Meredith E. Davis-Gardner, Bethany L. Dearlove, Han Di, Meike Dittmann, Nicole A. Doria-Rose, Daniel C. Douek, Christian Drosten, Venkata-Viswanadh Edara, Ali Ellebedy, Thomas P. Fabrizio, Guido Ferrari, Will M. Fischer, William C. Florence, Ron A. M. Fouchier, John Franks, Adolfo García-Sastre, Adam Godzik, Ana Silvia Gonzalez-Reiche, Aubree Gordon, Bart L. Haagmans, Peter J. Halfmann, David D. Ho, Michael R. Holbrook, Yaoxing Huang, Sarah L. James, Lukasz Jaroszewski, Trushar Jeevan, Robert M. Johnson, Terry C. Jones, Astha Joshi, Yoshihiro Kawaoka, Lisa Kercher, Marion P. G. Koopmans, Bette Korber, Eilay Koren, Richard A. Koup, Eric B. LeGresley, Jacob E. Lemieux, Mariel J. Liebeskind, Zhuoming Liu, Brandi Livingston, James P. Logue, Yang Luo, Adrian B. McDermott, Margaret J. McElrath, Victoria A. Meliopoulos, Vineet D. Menachery, David C. Montefiori, Barbara Mühlemann, Vincent J. Munster, Jenny E. Munt, Manoj S. Nair, Antonia Netzl, Anna M. Niewiadomska, Sijy O’Dell, Andrew Pekosz, Stanley Perlman, Marjorie C. Pontelli, Barry Rockx, Morgane Rolland, Paul W. Rothlauf, Sinai Sacharen, Richard H. Scheuermann, Stephen D. Schmidt, Michael Schotsaert, Stacey Schultz-Cherry, Robert A. Seder, Mayya Sedova, Alessandro Sette, Reed S. Shabman, Xiaoying Shen, Pei-Yong Shi, Maulik Shukla, Viviana Simon, Spencer Stumpf, Nancy J. Sullivan, Larissa B. Thackray, James Theiler, Paul G. Thomas, Sanja Trifkovic, Sina Türeli, Samuel A. Turner, Maria A. Vakaki, Harm van Bakel, Laura A. VanBlargan, Leah R. Vincent, Zachary S. Wallace, Li Wang, Maple Wang, Pengfei Wang, Wei Wang, Scott C. Weaver, Richard J. Webby, Carol D. Weiss, David E. Wentworth, Stuart M. Weston, Sean P. J. Whelan, Bradley M. Whitener, Samuel H. Wilks, Xuping Xie, Baoling Ying, Hyejin Yoon, Bin Zhou, Tomer Hertz, Derek J. Smith, Michael S. Diamond, Diane J. Post, Mehul S. Suthar
Publikováno v:
Nature
The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants jeopardizes the protective antiviral immunity induced following infection or vaccination. To address the public health threat caused by the increasing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e896e07b5a30bbcb962870bf7aaa91b
https://www.repository.cam.ac.uk/handle/1810/335637
https://www.repository.cam.ac.uk/handle/1810/335637
Autor:
Daniel Solis, Lilin Lai, Barney S. Graham, Elham Bayat Mokhtari, Amarendra Pegu, Maria W. Flowers, Caroline Rose Ciric, Eli Boritz, Mehul S. Suthar, Malaya K. Sahoo, Richard J. Webby, Daniel C. Douek, Prakriti Mudvari, Meredith E. Davis-Gardner, Matthew Gagne, Adrian Creanga, Trushar Jeevan, Venkata-Viswanadh Edara, Katharine Floyd, Mamdouh Sibai, Jens Wrammert, Laila Hussaini, Alexandrine Derrien-Colemyn, Benjamin A. Pinsky, Kathy Stephens, Amy R. Henry, Sarah Bechnak, Thomas P. Fabrizio
Publikováno v:
New England Journal of Medicine. 385:664-666
Neutralizing Activity against SARS-CoV-2 Variants Among samples obtained from persons who had received the mRNA-1273 or BNT162b2 vaccines, neutralizing antibody titers against the B.1.617.1 variant...
Autor:
Resha Bajracharya, Adrienne G. Randolph, Xiaoqing Liu, Zifeng Yang, Clifford S. Guy, Yunceng Weng, Wenda Guan, Nanshan Zhong, Thomas N. Wight, Peter Vogel, Catherine J. Sanders, Nicholas Wohlgemuth, Stacey Schultz-Cherry, David F. Boyd, Richard E. Rothman, Andrew Pekosz, Richard J. Webby, Peter M. Mourani, Xi-zhi J. Guo, Tanya Novak, Yimin Li, Jeremy Chase Crawford, Margaret M Newhams, Paul G. Thomas, Kuan-Fu Chen, Stephania A. Cormier, Thomas P. Fabrizio, E. Kaitlynn Allen, Natalie K. Lee, Kathryn Shaw-Saliba
Publikováno v:
Nature
Severe respiratory infections can result in acute respiratory distress syndrome (ARDS)1. There are no effective pharmacological therapies that have been shown to improve outcomes for patients with ARDS. Although the host inflammatory response limits
Autor:
Robert G. Webster, Jeremy C. Jones, Elena A. Govorkova, Subrata Barman, Bindumadhav M. Marathe, Pascua Pnq, Thomas P. Fabrizio, Richard J. Webby, Patrick Seiler
Publikováno v:
Proc Natl Acad Sci U S A
Baloxavir marboxil (BXM) was approved in 2018 for treating influenza A and B virus infections. It is a first-in-class inhibitor targeting the endonuclease activity of the virus polymerase acidic (PA) protein. Clinical trial data revealed that PA amin
Autor:
Richard J. Webby, Elaine Tuomanen, Thomas P. Fabrizio, E. Kaitlynn Allen, Stacey Schultz-Cherry, Sean Cherry, Li Tang, Kim J Allison, Sjtrc Investigative Team, Chun-Yang Lin, Joshua Wolf, Jeremie H. Estepp, Maureen A. McGargill, Paul G. Thomas, Aditya H. Gaur
Publikováno v:
Open Forum Infectious Diseases
The efficacy of coronavirus disease 2019 (COVID-19) vaccines administered after COVID-19-specific monoclonal antibody is unknown, and “antibody interference” might hinder immune responses leading to vaccine failure. In an institutional review boa
Autor:
Richard Fredrickson, Lance A. Miller, Kristi P. Camp, Thomas P. Fabrizio, Granger Ridout, Trushar Jeevan, Robert E. Throm, Jeremy C. Jones, James Lowe, Xiu-Feng Wan, Solomon O. Odemuyiwa, Patrick Seiler, Richard J. Webby, Francesca Ferrara, Hyunsuh Kim, Leyi Wang
Publikováno v:
Vaccines, Vol 8, Iss 684, p 684 (2020)
Vaccines
Volume 8
Issue 4
Vaccines
Volume 8
Issue 4
To optimize the public health response to coronavirus disease 2019 (COVID-19), we must first understand the antibody response to individual proteins on the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) and the antibody&rsquo
Autor:
Philip A. Mudd, Anastasia A. Minervina, Mikhail V. Pogorelyy, Jackson S. Turner, Wooseob Kim, Elizaveta Kalaidina, Jan Petersen, Aaron J. Schmitz, Tingting Lei, Alem Haile, Allison M. Kirk, Robert C. Mettelman, Jeremy Chase Crawford, Thi H.O. Nguyen, Louise C. Rowntree, Elisa Rosati, Katherine A. Richards, Andrea J. Sant, Michael K. Klebert, Teresa Suessen, William D. Middleton, Joshua Wolf, Sharlene A. Teefey, Jane A. O’Halloran, Rachel M. Presti, Katherine Kedzierska, Jamie Rossjohn, Paul G. Thomas, Ali H. Ellebedy, Jeremie H. Estepp, Stacey Schultz-Cherry, Maureen A. McGargill, Aditya Gaur, James Hoffman, Motomi Mori, Li Tang, Elaine Tuomanen, Richard Webby, Randall T. Hayden, Hana Hakim, Diego R. Hijano, Kim J. Allison, E. Kaitlynn Allen, Resha Bajracharya, Walid Awad, Lee-Ann Van de Velde, Brandi L. Clark, Taylor L. Wilson, Aisha Souquette, Ashley Castellaw, Ronald H. Dallas, Ashleigh Gowen, Thomas P. Fabrizio, Chun-Yang Lin, David C. Brice, Sean Cherry, Ericka Kirkpatrick Roubidoux, Valerie Cortez, Pamela Freiden, Nicholas Wohlgemuth, Kendall Whitt
Publikováno v:
Cell
SARS-CoV-2 mRNA vaccines induce robust anti-spike (S) antibody and CD4+ T cell responses. It is not yet clear whether vaccine-induced follicular helper CD4+ T (TFH) cell responses contribute to this outstanding immunogenicity. Using fine needle aspir